ATAI Life Sciences N.V. Quarterly Debt-to-equity in % from Q1 2022 to Q2 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: ATAI Life Sciences N.V. quarterly Debt-to-equity history and growth rate from Q1 2022 to Q2 2024.
ATAI Life Sciences N.V. Debt-to-equity for the quarter ending June 30, 2024 was 20.2 %, a 23.1% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q2 2024	20.2	+3.8	+23.1%	Jun 30, 2024
Q1 2024	18.3	+4.17	+29.5%	Mar 31, 2024
Q4 2023	17.4	+5.46	+45.7%	Dec 31, 2023
Q3 2023	16.1	+6.08	+60.6%	Sep 30, 2023
Q2 2023	16.4	+9.19	+127%	Jun 30, 2023
Q1 2023	14.1	+8.06	+133%	Mar 31, 2023
Q4 2022	12			Dec 31, 2022
Q3 2022	10			Sep 30, 2022
Q2 2022	7.24			Jun 30, 2022
Q1 2022	6.06			Mar 31, 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.